Tuberculosis and serious infusion reactions in Japanese patients with rheumatoid arthritis: Results from the post marketing surveillance trial.

被引：0
作者：
Dabbous, Omar
Tatsuki, Yoshihiko
Rahman, Mirza I.
Gilmer, Keith
Arjunji, Ramesh
Thompson, Heidi
Togo, Masanori
Tang, Boxiong
Suzuki, Toshikazu
机构：
[1] Tanabe Seiyaku Co Ltd, Osaka, Japan
[2] Centocor Inc, Horsham, PA USA
来源：
ARTHRITIS AND RHEUMATISM | 2006年 / 54卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S422 / S422
页数：1
相关论文
共 50 条
  • [41] Aflibercept with FOLFIRI in Japanese patients with metastatic colorectal cancer: results of a post-marketing surveillance
    Watanabe, Jun
    Terazawa, Tetsuji
    Yamane, Shiho
    Kazama, Hirotaka
    Uetake, Hiroyuki
    Yoshino, Takayuki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2023, 28 (01) : 130 - 138
  • [42] SAFETY AND EFFECTIVENESS OF BEVACIZUMAB IN JAPANESE PATIENTS WITH MALIGNANT GLIOMA: POST-MARKETING SURVEILLANCE RESULTS
    Nishikawa, Ryo
    Nagane, Motoo
    Shimizu, Ayaka
    Tamura, Takashi
    Ura, Masako
    NEURO-ONCOLOGY, 2017, 19 : 8 - 8
  • [43] Safety and effectiveness of switching from infliximab to etanercept in patients with rheumatoid arthritis: results from a large Japanese postmarketing surveillance study
    Koike, Takao
    Harigai, Masayoshi
    Inokuma, Shigeko
    Ishiguro, Naoki
    Ryu, Junnosuke
    Takeuchi, Tsutomu
    Tanaka, Yoshiya
    Yamanaka, Hisashi
    Fujii, Koichi
    Yoshinaga, Takunari
    Freundlich, Bruce
    Suzukawa, Michio
    RHEUMATOLOGY INTERNATIONAL, 2012, 32 (06) : 1617 - 1624
  • [44] Safety and effectiveness of switching from infliximab to etanercept in patients with rheumatoid arthritis: results from a large Japanese postmarketing surveillance study
    Takao Koike
    Masayoshi Harigai
    Shigeko Inokuma
    Naoki Ishiguro
    Junnosuke Ryu
    Tsutomu Takeuchi
    Yoshiya Tanaka
    Hisashi Yamanaka
    Koichi Fujii
    Takunari Yoshinaga
    Bruce Freundlich
    Michio Suzukawa
    Rheumatology International, 2012, 32 : 1617 - 1624
  • [45] Safety and Efficacy of Fingolimod in Japanese Patients with Multiple Sclerosis: Interim Analysis Results from Post-marketing Surveillance
    Kira, J.
    Fujihara, K.
    Ueda, K.
    Tajima, T.
    Ueno, M.
    Saida, T.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (07) : 928 - 928
  • [46] POST-MARKETING SURVEILLANCE OF EFFICACY AND SAFETY OF TACROLIMUS ADD-ON THERAPY IN JAPANESE RHEUMATOID ARTHRITIS PATIENTS WITHOUT AN ADEQUATE RESPONSE TO BIOLOGICAL DMARDS
    Takeuchi, T.
    Ishida, K.
    Shiraki, K.
    Yoshiyasu, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 261 - 262
  • [47] Safety and effectiveness of apremilast in Japanese patients with psoriatic disease: Results of a post-marketing surveillance study
    Ohtsuki, Mamitaro
    Okubo, Yukari
    Saeki, Hidehisa
    Igarashi, Atsuyuki
    Imafuku, Shinichi
    Abe, Masatoshi
    Chaudhari, Siddharth
    Yaguchi, Masafumi
    Emoto, Ayumi
    Morita, Akimichi
    JOURNAL OF DERMATOLOGY, 2024, 51 (07) : 950 - 963
  • [48] An innovative approach to practice based post-marketing surveillance of rheumatoid arthritis using an established patient surveillance system: Results of a feasibility study
    Bombardier, Claire
    Ciurea, Ileana
    English, Janine
    Wilkins, Annette
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (06) : 1196 - 1197
  • [49] Effect of Golimumab Dose Escalation in Japanese Patients With Rheumatoid Arthritis: Post-Hoc Analysis of Post-Marketing Surveillance Data (vol 7, pg 311, 2020)
    Shimizu, Hirohito
    Kobayashi, Hisanori
    Kanbori, Masayoshi
    Ishii, Yutaka
    RHEUMATOLOGY AND THERAPY, 2020, 7 (04) : 1053 - 1053
  • [50] Infliximab rapidly improves all components of physical function assessed by the HAQ in patients with rheumatoid arthritis: Results from the START trial.
    Yocum, D
    Rahman, MU
    Han, CG
    Bala, M
    Han, J
    Westhovens, R
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S188 - S189
12345